| The microtubule plus-end tracking protein EB1 is required for Kv1 voltage-gated K+ channel axonal targeting C Gu, W Zhou, MA Puthenveedu, M Xu, YN Jan, LY Jan Neuron 52 (5), 803-816, 2006 | 155 | 2006 |
| Phase 2 study of pembrolizumab in patients with advanced rare cancers A Naing, F Meric-Bernstam, B Stephen, DD Karp, J Hajjar, JR Ahnert, ... Journal for immunotherapy of cancer 8 (1), 2020 | 131 | 2020 |
| Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma MA Habra, B Stephen, M Campbell, K Hess, C Tapia, M Xu, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 129 | 2019 |
| A hierarchy of ankyrin-spectrin complexes clusters sodium channels at nodes of Ranvier TSY Ho, DR Zollinger, KJ Chang, M Xu, EC Cooper, MC Stankewich, ... Nature neuroscience 17 (12), 1664-1672, 2014 | 109 | 2014 |
| Ankyrin-G isoform imbalance and interneuronopathy link epilepsy and bipolar disorder AY Lopez, X Wang, M Xu, A Maheshwari, D Curry, S Lam, AM Adesina, ... Molecular psychiatry 22 (10), 1464-1472, 2017 | 71 | 2017 |
| An ankyrin-G N-terminal gate and protein kinase CK2 dually regulate binding of voltage-gated sodium and KCNQ2/3 potassium channels M Xu, EC Cooper Journal of Biological Chemistry 290 (27), 16619-16632, 2015 | 69 | 2015 |
| The Axon–Dendrite Targeting of Kv3 (Shaw) Channels Is Determined by a Targeting Motif That Associates with the T1 Domain and Ankyrin G M Xu, R Cao, R Xiao, MX Zhu, C Gu The Journal of Neuroscience 27 (51), 14158, 2007 | 64 | 2007 |
| Phase II clinical trial of pembrolizumab in patients with progressive metastatic pheochromocytomas and paragangliomas C Jimenez, V Subbiah, B Stephen, J Ma, D Milton, M Xu, A Zarifa, ... Cancers 12 (8), 2307, 2020 | 57 | 2020 |
| Kinesin I transports tetramerized Kv3 channels through the axon initial segment via direct binding M Xu, Y Gu, J Barry, C Gu Journal of Neuroscience 30 (47), 15987-16001, 2010 | 56 | 2010 |
| Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study N Majd, SG Waguespack, F Janku, S Fu, M Penas-Prado, M Xu, ... Journal for immunotherapy of cancer 8 (2), 2020 | 53 | 2020 |
| Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract M Frumovitz, SN Westin, G Salvo, A Zarifa, M Xu, TA Yap, AJ Rodon, ... Gynecologic oncology 158 (3), 570-575, 2020 | 51 | 2020 |
| Channel-anchored protein kinase CK2 and protein phosphatase 1 reciprocally regulate KCNQ2-containing M-channels via phosphorylation of calmodulin S Kang, M Xu, EC Cooper, N Hoshi Journal of Biological Chemistry 289 (16), 11536-11544, 2014 | 44 | 2014 |
| Role of exchange protein directly activated by cyclic AMP isoform 1 in energy homeostasis: regulation of leptin expression and secretion in white adipose tissue Y Hu, WG Robichaux III, FC Mei, ER Kim, H Wang, Q Tong, J Jin, M Xu, ... Molecular and cellular biology, 2016 | 24 | 2016 |
| Activation of conventional kinesin motors in clusters by Shaw voltage-gated K+ channels J Barry, M Xu, Y Gu, AW Dangel, P Jukkola, C Shrestha, C Gu Journal of cell science 126 (9), 2027-2041, 2013 | 22 | 2013 |
| Characterization of the genetic components of Streptomyces lividans linear plasmid SLP2 for replication in circular and linear modes M Xu, Y Zhu, R Zhang, M Shen, W Jiang, G Zhao, Z Qin Journal of bacteriology 188 (19), 6851, 2006 | 18 | 2006 |
| The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial JA How, A Jazaeri, SN Westin, AK Sood, LM Ramondetta, M Xu, ... Investigational new drugs 39, 829-835, 2021 | 10 | 2021 |
| Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors C Tapia, PP Aung, S Roy-Chowdhuri, M Xu, F Ouyang, A Alshawa, ... Journal for immunotherapy of cancer 8 (1), 2020 | 10 | 2020 |
| Haplotype analysis of the T-cell receptor beta (TCRB) locus by long-amplicon TCRB repertoire sequencing TJ Looney, DY Duose, G Lowman, E Linch, J Hajjar, D Topacio-Hall, ... Journal of Immunotherapy and Precision Oncology 2 (4), 137-143, 2019 | 10* | 2019 |
| T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy B Stephen, J Hajjar, S Sarda, DY Duose, JM Conroy, C Morrison, ... Journal for immunotherapy of cancer 11 (8), 2023 | 9 | 2023 |
| Two KCNQ2 encephalopathy variants in the calmodulin-binding helix A exhibit dominant-negative effects and altered PIP2 interaction B Tran, ZG Ji, M Xu, TN Tsuchida, EC Cooper Frontiers in Physiology 11, 571813, 2020 | 8 | 2020 |
